Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Sanofi | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: Sanofi

Pharmaceutical sales up 3% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi
1Q Revenues: €8.4 billion  (+6%)
1Q Earnings: €1.8 billion (+11%)
Comments: Pharmaceutical sales were €6.3 billion in the quarter, up 3%. Genzyme sales were up 31% to €2.0 billion, driven by Dupixent, with sales of €329 million, and consolidation of Bioverativ. Vaccines sales were up 21% to €873 million, reflecting growth of Pentaxim in China and Menactra in Emerging Markets. Primary Care sales were down 17% to €2.3 billion  impacted by lower diabetes sales and divestiture of EU generics. Established product sales were down 9% to €2.5 billion. Lovenox sales were down 12% to €343 million, due to biosimilar competition in several countries in Europe. Plavix sales were up 3% to €404 million. Aprovel/Avapro sales were up 15% to €201 million. Renvela/Renagel sales were down 26% to €79 million due to generic competition in the U.S.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters